Clinical Trial: A Study on the Efficacy, Safety, and Population Pharmacokinetics/Pharmacodynamics of Remimazolam Tosilate versus Propofol for Sedation in Mechanically Ventilated ICU Patients (China)

Posted On: 2026-10-12

China, Oct. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Study on the Efficacy, Safety, and Population Pharmacokinetics/Pharmacodynamics of Remimazolam Tosilate versus Propofol for Sedation in Mechanically Ventilated ICU Patients'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600133956

Registration Time: 2026/10/09

Type: Interventional study

Primary Sponsor: TAIZHOU HOSPITAL OF ZHEJIANG PROVINCE

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=337768

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: A Study on the Efficacy, Safety, and Population Pharmacokinetics/Pharmacodynamics of Remimazolam Tosilate versus Propofol for Sedation in Mechanically Ventilated ICU Patients (China)